PTC Therapeutics
PTCT
NZ$80.74
Share price
-1.96%
Change (1 day)
48.63%
Change (1 year)
Categories
PTC Therapeutics (PTCT) - Total debt
Total debt on the balance sheet as of March 2025 : NZ$0.64 Billion
According to PTC Therapeutics 's latest financial reports the company's total debt is NZ$0.64 Billion. A company’s total debt is the sum of all current and non-current debts.
PTC Therapeutics - Total debt on balance sheet (from 2012 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$4.38 B | 24.3% |
| 2023-12-31 | NZ$3.52 B | 53.12% |
| 2022-12-31 | NZ$2.30 B | 23.87% |
| 2021-12-31 | NZ$1.85 B | 218.93% |
| 2020-12-31 | NZ$0.58 B | 19.63% |
| 2019-12-31 | NZ$0.48 B | 113.52% |
| 2018-12-31 | NZ$0.22 B | 11.75% |
| 2017-12-31 | NZ$0.20 B | 43.96% |
| 2016-12-31 | NZ$0.14 B | 5.66% |
| 2015-12-31 | NZ$0.13 B | |
| 2014-12-31 | N/A | -100% |
| 2013-12-31 | NZ$0.05 M | -99% |
| 2012-12-31 | NZ$5.93 M | -60.37% |
| 2011-12-31 | NZ$14.97 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Vertex Pharmaceuticals VRTX | NZ$2.74 B | 323.26% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | NZ$2.23 B | 244.89% | 🇺🇸 USA |
 Fate Therapeutics
FATE | NZ$0.13 B | -78.61% | 🇺🇸 USA |
 Avidity Biosciences RNA | NZ$9.93 M | -98.47% | 🇺🇸 USA |
 Xencor XNCR | NZ$0.11 B | -82.59% | 🇺🇸 USA |
 Novartis NVS | NZ$52.00 B | 7,925.87% | 🇨🇭 Switzerland |